The cost-effectiveness of methadone maintenance.

Area of Science:

• Health Economics
• Public Health Policy
• Addiction Medicine

Background:

• Methadone maintenance is effective for opiate abuse but faces limited access and provider non-compliance with guidelines.
• Public policy and moral judgments influence the U.S. methadone treatment system.
• Evaluating methadone cost-effectiveness can inform policy changes.

Purpose of the Study:

• To conduct a cost-effectiveness analysis of methadone maintenance treatment from an economic perspective.
• To address key policy questions regarding methadone as a health care benefit, optimal ancillary services, dosage, treatment duration, and contingency contracts.

Main Methods:

• Cost-effectiveness analysis comparing methadone treatment variations to standard care.
• Review of existing literature on methadone maintenance from an economic viewpoint.
• Focus on five critical policy-related questions.

Main Results:

• Expanded methadone access shows a cost-effectiveness ratio under $11,000 per Quality-Adjusted Life Year, comparable to other medical therapies.
• Evidence suggests many programs use inadequate methadone doses and short treatment durations, impacting cost-effectiveness.
• Ancillary services are beneficial, but optimal levels require further study; contingency contracts' cost-effectiveness needs demonstration.

Conclusions:

• Cost-effectiveness research should prioritize Quality-Adjusted Life Years for policy relevance in substance abuse treatment.
• Standardized outcome measurement will enable comparisons between different substance abuse interventions and general medical care.